MedPath

A pharmacist-delivered smoking cessation program in community pharmacy: a cluster-randomized trial

Not Applicable
Conditions
Smokers
Registration Number
JPRN-UMIN000032063
Lead Sponsor
Osaka University of Pharmaceutical Sciences
Brief Summary

572 smokers who met the eligibility criteria visited the target pharmacies. Of these, 24 patients agreed to participate in the study. Smoking cessation rates were 45.5% in the intervention group and 18.2% in the control group (P = 0:380, effect size = 0:60).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

1) Dementia or psychiatric disorders 2) Allergies or adverse effects with smoking cessation aids 3) Temporomandibular Joint Disorder (in the case of nicotine gum) 4) Pregnant women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Carbon Monoxide-verified Abstinence or Color reaction of YANIKEN-verified Abstinence [ Time Frame: Week 12]
Secondary Outcome Measures
NameTimeMethod
1) Number of recommended cases to a smoking cessation clinic and visiting cases 2) Satisfaction score with pharmacist-delivered smoking cessation program 3) Recommendation score with pharmacist-delivered smoking cessation program
© Copyright 2025. All Rights Reserved by MedPath